[Makmiror-complex in the treatment of post-radiation infectious vulvovaginitis in cancer patients].
The results of clinical trials of Makmiror-Complex for treatment of infectious vulvovaginitis of mixed etiology are discussed. The study group included 15 patients, aged 18-50, who contracted infectious vulvovaginitis of mixed etiology in the course or shortly after radiation and/or chemotherapy for tumors. The drug proved highly effective.